Hillsdale Investment Management »

Cymabay Therapeutics shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Cymabay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cymabay Therapeutics held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cymabay Therapeutics by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.3k 310 23.62
2023-09-30 $5.1k 340 14.91
2020-12-31 $708k 123k 5.74
2020-09-30 $1.2M 163k 7.24
2020-06-30 $755k 216k 3.49
2018-03-31 $104k 8.0k 13.00